Compare GEO & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GEO | INDV |
|---|---|---|
| Founded | 1984 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.4B |
| IPO Year | 1996 | 2014 |
| Metric | GEO | INDV |
|---|---|---|
| Price | $30.88 | $40.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $39.67 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 1.6M |
| Earning Date | 05-06-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 727.27 | ★ 8100.00 |
| EPS | 0.29 | ★ 0.69 |
| Revenue | ★ $2,263,420,000.00 | $1,239,000,000.00 |
| Revenue This Year | $13.74 | N/A |
| Revenue Next Year | $9.99 | N/A |
| P/E Ratio | $107.52 | ★ $58.71 |
| Revenue Growth | 3.85 | ★ 4.29 |
| 52 Week Low | $12.51 | $16.69 |
| 52 Week High | $32.25 | $42.81 |
| Indicator | GEO | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 62.29 | 53.87 |
| Support Level | $28.74 | $39.20 |
| Resistance Level | $32.25 | $41.42 |
| Average True Range (ATR) | 0.98 | 1.37 |
| MACD | -0.10 | -0.15 |
| Stochastic Oscillator | 64.11 | 56.03 |
The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services. The company operates in U.S, Australia and South Africa.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).